Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein

Vaccines are central to controlling the coronavirus disease 2019 (COVID-19) pandemic but the durability of protection is limited for currently approved COVID-19 vaccines. Further, the emergence of variants of concern (VoCs) that evade immune recognition has reduced vaccine effectiveness, compounding...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeonsu, Jacobsen, Henning, Fuerholzner, Bettina, Eschke, Kathrin, Hoffmann, Markus, Chaudhry, M.Zeeshan, Bertoglio, Federico, Hust, Michael, Widera, Marek, Ciesek, Sandra, Pöhlmann, Stefan, Čičin-Šain, Luka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727759/
https://www.ncbi.nlm.nih.gov/pubmed/36482969
http://dx.doi.org/10.1101/2022.11.25.517953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727759/
https://www.ncbi.nlm.nih.gov/pubmed/36482969
http://dx.doi.org/10.1101/2022.11.25.517953

Ejemplares similares